# Liver Transplant Combined With Neoadjuvant Chemo-radiotherapy in the Treatment of Unresectable Hilar Cholangiocarcinoma. A Prospective Multicenter Study.

> **NCT04378023** · — · RECRUITING · sponsor: **Hospital Vall d'Hebron** · enrollment: 34 (estimated)

## Conditions studied

- Unresectable Cholangiocarcinoma

## Interventions

- **DRUG:** Neoadjuvant Chemo-radiotherapy
- **PROCEDURE:** Liver Transplantation

## Key facts

- **NCT ID:** NCT04378023
- **Lead sponsor:** Hospital Vall d'Hebron
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2020-04-24
- **Primary completion:** 2027-06-01
- **Final completion:** 2027-06-01
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2025-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04378023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04378023, "Liver Transplant Combined With Neoadjuvant Chemo-radiotherapy in the Treatment of Unresectable Hilar Cholangiocarcinoma. A Prospective Multicenter Study.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04378023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*